Clarivate PLC (CLVT) News
Filter CLVT News Items
CLVT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CLVT News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest CLVT News From Around the Web
Below are the latest news stories about CLARIVATE PLC that investors may wish to consider to help them evaluate CLVT as an investment opportunity.
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch ReportClarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to redefine the future of healthcare. This year, the highly anticipated resource highlights 11 drugs projected to achieve blockbuster status or revolutionize treatment paradigms within five years. Since its inception, Drugs to Watch has identified over 98 transformative therapies, cementing its role a |
Is There An Opportunity With Clarivate Plc's (NYSE:CLVT) 28% Undervaluation?Key Insights The projected fair value for Clarivate is US$6.95 based on 2 Stage Free Cash Flow to Equity Current share... |
Clarivate Announces New $500 Million Share Repurchase AuthorizationClarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that its Board of Directors (the "Board") authorized a new share repurchase program of up to $500 million of the Company's outstanding ordinary shares through open-market purchases for a period of two years, from January 1, 2025 through December 31, 2026. |
Clarivate Launches AI-Powered Patent Search Solution in DerwentClarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of AI Search in Derwent™. Combining artificial intelligence (AI) with the premier source of global patent data, Derwent World Patents Index (DWPI)™, this solution will enable intellectual property (IP) professionals to make reliable innovation decisions by finding more relevant patents in less time. |
Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research FrontsClarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the Chinese Academy of Sciences (CAS) today released 2024 Research Fronts™, identifying the most dynamic and rapidly growing specialties in sciences and social sciences. This marks the eleventh annual collaboration between the two organizations, with the report launched at a ceremony held in Beijing today. |
Daikin Selects IPfolio from ClarivateClarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Daikin Industries, Ltd. (Daikin) has selected IPfolio™ from Clarivate. The leading air conditioner manufacturer will utilize this solution to optimize its intellectual property (IP) assets, enabling more confident strategic decision-making and sustainable growth. |
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special SeriesBioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, 'Healing the Health Divide.' This seven-part series sheds light on the persistent disparities in women's health research, funding, and treatment. |
Clarivate Reveals Highly Cited Researchers 2024 ListClarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2024 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research. |
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global InfluenceClarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade of Innovation, A Decade to Come. |
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award WinnersClarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the 2023 winners of the Clarivate Healthcare Business Insights™ annual Revenue Cycle Awards. Now in its 12th year, the Revenue Cycle Awards recognize U.S.-based healthcare organizations for exceptional performance on revenue cycle KPIs, based on data from their most recent and preceding full fiscal years. The 2023 recipients include Roper St. Francis Healthcare (Physician Group) – SC; Bon Secours Mercy |